Sort   by:  
 Page size 
UnknownIdentifying the immune interactions underlying HLA class I disease associations.
Not available
S-EPMC7253178 | biostudies-literature
UnknownUnrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centres.
Not available
S-EPMC11607406 | biostudies-literature
UnknownBiomarkers as Common Data Elements for Symptom and Self-Management Science.
Not available
S-EPMC5945303 | biostudies-literature
UnknownMulti-ancestry polygenic risk scores for the prediction of type 2 diabetes and complications in diverse ancestries.
Not available
S-EPMC12330429 | biostudies-literature
UnknownGenetic drivers of heterogeneity in type 2 diabetes pathophysiology.
Not available
S-EPMC10937372 | biostudies-literature
UnknownMulti-ancestry genome-wide study in >2.5 million individuals reveals heterogeneity in mechanistic pathways of type 2 diabetes and complications.
Not available
S-EPMC10081410 | biostudies-literature
UnknownMulti-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation.
Not available
S-EPMC9179018 | biostudies-literature
UnknownBurden of disease scenarios by state in the USA, 2022-50: a forecasting analysis for the Global Burden of Disease Study 2021.
Not available
S-EPMC11715278 | biostudies-literature
UnknownGlobal Burden of Cardiovascular Diseases and Risks, 1990-2022.
Not available
S-EPMC7615984 | biostudies-literature
UnknownBurden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
Not available
S-EPMC12535840 | biostudies-literature
Sort   by:  
 Page size